+关注
糊涂虫141319
暂无个人介绍
IP属地：四川
15
关注
0
粉丝
0
主题
0
勋章
主贴
热门
糊涂虫141319
08-30 06:14
$Hims & Hers Health Inc.(HIMS)$
糊涂虫141319
08-11
错杀那么好的公司，业绩也好，利润也好
糊涂虫141319
08-05
$Hims & Hers Health Inc.(HIMS)$
糊涂虫141319
08-05
搞不懂业绩这么好还是跌
Hims & Hers 二季度营收增长73%，但未达预期
糊涂虫141319
08-05
为什么这也不是很差的预期，为什么还暴跌，看不懂
Hims & Hers Health Q2营收5.45亿美元，同比增长73%
糊涂虫141319
08-05
$Hims & Hers Health Inc.(HIMS)$
糊涂虫141319
06-20
$特斯拉(TSLA)$
横盘那么多天了又有利好
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4206954846470532","uuid":"4206954846470532","gmtCreate":1747197266785,"gmtModify":1748254280658,"name":"糊涂虫141319","pinyin":"htc141319hutuchong141319","introduction":"","introductionEn":null,"signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":15,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.28","exceedPercentage":"80.53%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.07","exceedPercentage":"93.26%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":8,"crmLevelSwitch":0,"location":"四川","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":14,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":472982316360336,"gmtCreate":1756505690561,"gmtModify":1756505691288,"author":{"id":"4206954846470532","authorId":"4206954846470532","name":"糊涂虫141319","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4206954846470532","idStr":"4206954846470532"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HIMS\">$Hims & Hers Health Inc.(HIMS)$ </a><v-v data-views=\"1\"></v-v> ","listText":"<a href=\"https://laohu8.com/S/HIMS\">$Hims & Hers Health Inc.(HIMS)$ </a><v-v data-views=\"1\"></v-v> ","text":"$Hims & Hers Health Inc.(HIMS)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/472982316360336","isVote":1,"tweetType":1,"viewCount":49,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":466396159815856,"gmtCreate":1754891149709,"gmtModify":1754891151539,"author":{"id":"4206954846470532","authorId":"4206954846470532","name":"糊涂虫141319","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4206954846470532","idStr":"4206954846470532"},"themes":[],"htmlText":"错杀那么好的公司，业绩也好，利润也好","listText":"错杀那么好的公司，业绩也好，利润也好","text":"错杀那么好的公司，业绩也好，利润也好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/466396159815856","isVote":1,"tweetType":1,"viewCount":417,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":464344503148928,"gmtCreate":1754390956979,"gmtModify":1754390957710,"author":{"id":"4206954846470532","authorId":"4206954846470532","name":"糊涂虫141319","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4206954846470532","idStr":"4206954846470532"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HIMS\">$Hims & Hers Health Inc.(HIMS)$ </a><v-v data-views=\"1\"></v-v> ","listText":"<a href=\"https://laohu8.com/S/HIMS\">$Hims & Hers Health Inc.(HIMS)$ </a><v-v data-views=\"1\"></v-v> ","text":"$Hims & Hers Health Inc.(HIMS)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/464344503148928","isVote":1,"tweetType":1,"viewCount":308,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":464210414006680,"gmtCreate":1754358199482,"gmtModify":1754359107027,"author":{"id":"4206954846470532","authorId":"4206954846470532","name":"糊涂虫141319","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4206954846470532","idStr":"4206954846470532"},"themes":[],"htmlText":"搞不懂业绩这么好还是跌","listText":"搞不懂业绩这么好还是跌","text":"搞不懂业绩这么好还是跌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/464210414006680","repostId":"1199873405","repostType":4,"repost":{"id":"1199873405","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1754349563,"share":"https://www.laohu8.com/m/news/1199873405?lang=&edition=full","pubTime":"2025-08-05 07:19","market":"hk","language":"zh","title":"Hims & Hers 二季度营收增长73%，但未达预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1199873405","media":"老虎资讯综合","summary":"关键点Hims & Hers Health 股价在盘后交易中下跌，此前该公司公布的第二季度营收未达到华尔街的营收预期。Hims & Hers 报告第二季度调整后 EBITDA 为8200万美元，高于去年同期的3930万美元。对于第三季度，Hims & Hers 表示预计营收将在5.7亿至5.9亿美元之间，而分析师预期为5.83亿美元。Hims & Hers 表示，如果临床适用，消费者可能仍能通过其网站获得个性化剂量。诺和诺德表示，Hims & Hers “在个性化的虚假幌子下，未能遵守禁止大规模销售复合药物的法律”。","content":"<html><head></head><body><p style=\"text-align: start;\"><strong>关键点</strong></p><ul style=\"\"><li><p>Hims & Hers Health 股价在盘后交易中下跌，此前该公司公布的第二季度营收未达到华尔街的营收预期。</p></li><li><p>营收同比增长73%，达到5.448亿美元。</p></li><li><p>Hims & Hers 报告第二季度调整后 EBITDA 为8200万美元，高于去年同期的3930万美元。</p></li></ul><p style=\"text-align: start;\">Hims & Hers Health (HIMS) 股价周一盘后下跌13%，此前这家远程医疗公司公布的第二季度业绩未达到华尔街的营收预期。</p><p></p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/35dbaa7fe50863ac71a93584bd75c783\" tg-width=\"528\" tg-height=\"154\"/></p><p style=\"text-align: start;\">根据伦敦证券交易所集团（LSEG）汇编的分析师平均预期，该公司业绩如下：</p><ul style=\"\"><li><p><strong>每股收益：</strong> 调整后为17美分，预期为15美分</p></li><li><p><strong>营收：</strong> 5.448亿美元，预期为5.52亿美元</p></li></ul><p style=\"text-align: start;\">根据公告，Hims & Hers 第二季度营收为5.448亿美元，较去年同期的3.156亿美元增长73%。该公司报告净利润为4250万美元，合每股收益17美分；而去年同期净利润为1330万美元，合每股收益6美分。</p><p style=\"text-align: start;\">对于第三季度，Hims & Hers 表示预计营收将在5.7亿至5.9亿美元之间，而分析师预期为5.83亿美元。该公司表示，其第三季度调整后的利息、税项、折旧及摊销前利润（EBITDA）预计在6000万至7000万美元之间。StreetAccount 调查的分析师预期为7710万美元。</p><p style=\"text-align: start;\"><strong>争议背景</strong></p><p style=\"text-align: start;\">Hims & Hers 近几个月因其持续销售<strong>复合GLP-1药物</strong>而面临争议。这些药物是热门糖尿病和减肥药物的更便宜、未经批准的版本。当品牌药供应短缺时，复合药物可以大规模生产，但美国食品药品监督管理局（FDA）在2月份宣布，持续的供应问题已得到解决。</p><p style=\"text-align: start;\">包括 Hims & Hers 在内的一些远程医疗公司仍在继续提供这些复合药物。在法律允许的特殊情况下（例如患者对品牌药中的某种成分过敏），患者获取个性化剂量的仿制药是合法的。Hims & Hers 表示，如果临床适用，消费者可能仍能通过其网站获得个性化剂量。</p><p style=\"text-align: start;\">6月，Hims & Hers 与诺和诺德（Novo Nordisk）的短暂合作破裂后，其股价曾暴跌逾30%。诺和诺德表示，Hims & Hers “在个性化的虚假幌子下，未能遵守禁止大规模销售复合药物的法律”。</p><p style=\"text-align: start;\"><strong>其他财务数据</strong></p><p style=\"text-align: start;\">Hims & Hers 报告第二季度调整后 EBITDA 为8200万美元，高于去年同期的3930万美元，也高于 StreetAccount 预期的7300万美元。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hims & Hers 二季度营收增长73%，但未达预期</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHims & Hers 二季度营收增长73%，但未达预期\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2025-08-05 07:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p style=\"text-align: start;\"><strong>关键点</strong></p><ul style=\"\"><li><p>Hims & Hers Health 股价在盘后交易中下跌，此前该公司公布的第二季度营收未达到华尔街的营收预期。</p></li><li><p>营收同比增长73%，达到5.448亿美元。</p></li><li><p>Hims & Hers 报告第二季度调整后 EBITDA 为8200万美元，高于去年同期的3930万美元。</p></li></ul><p style=\"text-align: start;\">Hims & Hers Health (HIMS) 股价周一盘后下跌13%，此前这家远程医疗公司公布的第二季度业绩未达到华尔街的营收预期。</p><p></p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/35dbaa7fe50863ac71a93584bd75c783\" tg-width=\"528\" tg-height=\"154\"/></p><p style=\"text-align: start;\">根据伦敦证券交易所集团（LSEG）汇编的分析师平均预期，该公司业绩如下：</p><ul style=\"\"><li><p><strong>每股收益：</strong> 调整后为17美分，预期为15美分</p></li><li><p><strong>营收：</strong> 5.448亿美元，预期为5.52亿美元</p></li></ul><p style=\"text-align: start;\">根据公告，Hims & Hers 第二季度营收为5.448亿美元，较去年同期的3.156亿美元增长73%。该公司报告净利润为4250万美元，合每股收益17美分；而去年同期净利润为1330万美元，合每股收益6美分。</p><p style=\"text-align: start;\">对于第三季度，Hims & Hers 表示预计营收将在5.7亿至5.9亿美元之间，而分析师预期为5.83亿美元。该公司表示，其第三季度调整后的利息、税项、折旧及摊销前利润（EBITDA）预计在6000万至7000万美元之间。StreetAccount 调查的分析师预期为7710万美元。</p><p style=\"text-align: start;\"><strong>争议背景</strong></p><p style=\"text-align: start;\">Hims & Hers 近几个月因其持续销售<strong>复合GLP-1药物</strong>而面临争议。这些药物是热门糖尿病和减肥药物的更便宜、未经批准的版本。当品牌药供应短缺时，复合药物可以大规模生产，但美国食品药品监督管理局（FDA）在2月份宣布，持续的供应问题已得到解决。</p><p style=\"text-align: start;\">包括 Hims & Hers 在内的一些远程医疗公司仍在继续提供这些复合药物。在法律允许的特殊情况下（例如患者对品牌药中的某种成分过敏），患者获取个性化剂量的仿制药是合法的。Hims & Hers 表示，如果临床适用，消费者可能仍能通过其网站获得个性化剂量。</p><p style=\"text-align: start;\">6月，Hims & Hers 与诺和诺德（Novo Nordisk）的短暂合作破裂后，其股价曾暴跌逾30%。诺和诺德表示，Hims & Hers “在个性化的虚假幌子下，未能遵守禁止大规模销售复合药物的法律”。</p><p style=\"text-align: start;\"><strong>其他财务数据</strong></p><p style=\"text-align: start;\">Hims & Hers 报告第二季度调整后 EBITDA 为8200万美元，高于去年同期的3930万美元，也高于 StreetAccount 预期的7300万美元。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://community-static.tradeup.com/news/8e1c456ca197d0f36009334944bbbcef","relate_stocks":{"HIMS":"Hims & Hers Health Inc."},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199873405","content_text":"关键点Hims & Hers Health 股价在盘后交易中下跌，此前该公司公布的第二季度营收未达到华尔街的营收预期。营收同比增长73%，达到5.448亿美元。Hims & Hers 报告第二季度调整后 EBITDA 为8200万美元，高于去年同期的3930万美元。Hims & Hers Health (HIMS) 股价周一盘后下跌13%，此前这家远程医疗公司公布的第二季度业绩未达到华尔街的营收预期。根据伦敦证券交易所集团（LSEG）汇编的分析师平均预期，该公司业绩如下：每股收益： 调整后为17美分，预期为15美分营收： 5.448亿美元，预期为5.52亿美元根据公告，Hims & Hers 第二季度营收为5.448亿美元，较去年同期的3.156亿美元增长73%。该公司报告净利润为4250万美元，合每股收益17美分；而去年同期净利润为1330万美元，合每股收益6美分。对于第三季度，Hims & Hers 表示预计营收将在5.7亿至5.9亿美元之间，而分析师预期为5.83亿美元。该公司表示，其第三季度调整后的利息、税项、折旧及摊销前利润（EBITDA）预计在6000万至7000万美元之间。StreetAccount 调查的分析师预期为7710万美元。争议背景Hims & Hers 近几个月因其持续销售复合GLP-1药物而面临争议。这些药物是热门糖尿病和减肥药物的更便宜、未经批准的版本。当品牌药供应短缺时，复合药物可以大规模生产，但美国食品药品监督管理局（FDA）在2月份宣布，持续的供应问题已得到解决。包括 Hims & Hers 在内的一些远程医疗公司仍在继续提供这些复合药物。在法律允许的特殊情况下（例如患者对品牌药中的某种成分过敏），患者获取个性化剂量的仿制药是合法的。Hims & Hers 表示，如果临床适用，消费者可能仍能通过其网站获得个性化剂量。6月，Hims & Hers 与诺和诺德（Novo Nordisk）的短暂合作破裂后，其股价曾暴跌逾30%。诺和诺德表示，Hims & Hers “在个性化的虚假幌子下，未能遵守禁止大规模销售复合药物的法律”。其他财务数据Hims & Hers 报告第二季度调整后 EBITDA 为8200万美元，高于去年同期的3930万美元，也高于 StreetAccount 预期的7300万美元。","news_type":1,"symbols_score_info":{"HIMS":1.1}},"isVote":1,"tweetType":1,"viewCount":381,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":464152230854784,"gmtCreate":1754343502961,"gmtModify":1754343859109,"author":{"id":"4206954846470532","authorId":"4206954846470532","name":"糊涂虫141319","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4206954846470532","idStr":"4206954846470532"},"themes":[],"htmlText":"为什么这也不是很差的预期，为什么还暴跌，看不懂","listText":"为什么这也不是很差的预期，为什么还暴跌，看不懂","text":"为什么这也不是很差的预期，为什么还暴跌，看不懂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/464152230854784","repostId":"1154130468","repostType":2,"repost":{"id":"1154130468","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1754343017,"share":"https://www.laohu8.com/m/news/1154130468?lang=&edition=full","pubTime":"2025-08-05 05:30","market":"us","language":"zh","title":"Hims & Hers Health Q2营收5.45亿美元，同比增长73%","url":"https://stock-news.laohu8.com/highlight/detail?id=1154130468","media":"老虎资讯综合","summary":"$Hims & Hers Health(HIMS)$ Q2营收5.45亿美元，同比增长73%；净利润4250万美元，订阅人数同比增长31%至243.9万，2025年全年收入指引为23亿至24亿美元。","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/HIMS\">Hims & Hers Health</a> Q2营收5.45亿美元，同比增长73%；净利润4250万美元，订阅人数同比增长31%至243.9万，2025年全年收入指引为23亿至24亿美元。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/242f1c038b531dc3e6f481e123862e05\" alt=\"\" title=\"\" tg-width=\"1232\" tg-height=\"676\"/></p><p><br/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hims & Hers Health Q2营收5.45亿美元，同比增长73%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHims & Hers Health Q2营收5.45亿美元，同比增长73%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2025-08-05 05:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><a href=\"https://laohu8.com/S/HIMS\">Hims & Hers Health</a> Q2营收5.45亿美元，同比增长73%；净利润4250万美元，订阅人数同比增长31%至243.9万，2025年全年收入指引为23亿至24亿美元。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/242f1c038b531dc3e6f481e123862e05\" alt=\"\" title=\"\" tg-width=\"1232\" tg-height=\"676\"/></p><p><br/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/04d0654d12d8106ec177c462b61be25d","relate_stocks":{"HIMS":"Hims & Hers Health Inc.","LU0566484027.USD":"安本美国小盘成长股","LU1559883803.SGD":"Aberdeen Standard SICAV I - North American Smaller Companies Fund A Acc SGD-H","BK4023":"应用软件"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154130468","content_text":"Hims & Hers Health Q2营收5.45亿美元，同比增长73%；净利润4250万美元，订阅人数同比增长31%至243.9万，2025年全年收入指引为23亿至24亿美元。","news_type":1,"symbols_score_info":{"HIMS":1}},"isVote":1,"tweetType":1,"viewCount":312,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":464147141869704,"gmtCreate":1754342475441,"gmtModify":1754363797282,"author":{"id":"4206954846470532","authorId":"4206954846470532","name":"糊涂虫141319","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4206954846470532","idStr":"4206954846470532"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HIMS\">$Hims & Hers Health Inc.(HIMS)$ </a><v-v data-views=\"0\"></v-v> ","listText":"<a href=\"https://laohu8.com/S/HIMS\">$Hims & Hers Health Inc.(HIMS)$ </a><v-v data-views=\"0\"></v-v> ","text":"$Hims & Hers Health Inc.(HIMS)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/464147141869704","isVote":1,"tweetType":1,"viewCount":251,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":448112226586640,"gmtCreate":1750429174234,"gmtModify":1750429526297,"author":{"id":"4206954846470532","authorId":"4206954846470532","name":"糊涂虫141319","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4206954846470532","idStr":"4206954846470532"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$ </a><v-v data-views=\"1\"></v-v> 横盘那么多天了又有利好","listText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$ </a><v-v data-views=\"1\"></v-v> 横盘那么多天了又有利好","text":"$特斯拉(TSLA)$ 横盘那么多天了又有利好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/448112226586640","isVote":1,"tweetType":1,"viewCount":356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":472982316360336,"gmtCreate":1756505690561,"gmtModify":1756505691288,"author":{"id":"4206954846470532","authorId":"4206954846470532","name":"糊涂虫141319","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4206954846470532","idStr":"4206954846470532"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HIMS\">$Hims & Hers Health Inc.(HIMS)$ </a><v-v data-views=\"1\"></v-v> ","listText":"<a href=\"https://laohu8.com/S/HIMS\">$Hims & Hers Health Inc.(HIMS)$ </a><v-v data-views=\"1\"></v-v> ","text":"$Hims & Hers Health Inc.(HIMS)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/472982316360336","isVote":1,"tweetType":1,"viewCount":49,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":466396159815856,"gmtCreate":1754891149709,"gmtModify":1754891151539,"author":{"id":"4206954846470532","authorId":"4206954846470532","name":"糊涂虫141319","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4206954846470532","idStr":"4206954846470532"},"themes":[],"htmlText":"错杀那么好的公司，业绩也好，利润也好","listText":"错杀那么好的公司，业绩也好，利润也好","text":"错杀那么好的公司，业绩也好，利润也好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/466396159815856","isVote":1,"tweetType":1,"viewCount":417,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":464344503148928,"gmtCreate":1754390956979,"gmtModify":1754390957710,"author":{"id":"4206954846470532","authorId":"4206954846470532","name":"糊涂虫141319","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4206954846470532","idStr":"4206954846470532"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HIMS\">$Hims & Hers Health Inc.(HIMS)$ </a><v-v data-views=\"1\"></v-v> ","listText":"<a href=\"https://laohu8.com/S/HIMS\">$Hims & Hers Health Inc.(HIMS)$ </a><v-v data-views=\"1\"></v-v> ","text":"$Hims & Hers Health Inc.(HIMS)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/464344503148928","isVote":1,"tweetType":1,"viewCount":308,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":464210414006680,"gmtCreate":1754358199482,"gmtModify":1754359107027,"author":{"id":"4206954846470532","authorId":"4206954846470532","name":"糊涂虫141319","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4206954846470532","idStr":"4206954846470532"},"themes":[],"htmlText":"搞不懂业绩这么好还是跌","listText":"搞不懂业绩这么好还是跌","text":"搞不懂业绩这么好还是跌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/464210414006680","repostId":"1199873405","repostType":4,"repost":{"id":"1199873405","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1754349563,"share":"https://www.laohu8.com/m/news/1199873405?lang=&edition=full","pubTime":"2025-08-05 07:19","market":"hk","language":"zh","title":"Hims & Hers 二季度营收增长73%，但未达预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1199873405","media":"老虎资讯综合","summary":"关键点Hims & Hers Health 股价在盘后交易中下跌，此前该公司公布的第二季度营收未达到华尔街的营收预期。Hims & Hers 报告第二季度调整后 EBITDA 为8200万美元，高于去年同期的3930万美元。对于第三季度，Hims & Hers 表示预计营收将在5.7亿至5.9亿美元之间，而分析师预期为5.83亿美元。Hims & Hers 表示，如果临床适用，消费者可能仍能通过其网站获得个性化剂量。诺和诺德表示，Hims & Hers “在个性化的虚假幌子下，未能遵守禁止大规模销售复合药物的法律”。","content":"<html><head></head><body><p style=\"text-align: start;\"><strong>关键点</strong></p><ul style=\"\"><li><p>Hims & Hers Health 股价在盘后交易中下跌，此前该公司公布的第二季度营收未达到华尔街的营收预期。</p></li><li><p>营收同比增长73%，达到5.448亿美元。</p></li><li><p>Hims & Hers 报告第二季度调整后 EBITDA 为8200万美元，高于去年同期的3930万美元。</p></li></ul><p style=\"text-align: start;\">Hims & Hers Health (HIMS) 股价周一盘后下跌13%，此前这家远程医疗公司公布的第二季度业绩未达到华尔街的营收预期。</p><p></p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/35dbaa7fe50863ac71a93584bd75c783\" tg-width=\"528\" tg-height=\"154\"/></p><p style=\"text-align: start;\">根据伦敦证券交易所集团（LSEG）汇编的分析师平均预期，该公司业绩如下：</p><ul style=\"\"><li><p><strong>每股收益：</strong> 调整后为17美分，预期为15美分</p></li><li><p><strong>营收：</strong> 5.448亿美元，预期为5.52亿美元</p></li></ul><p style=\"text-align: start;\">根据公告，Hims & Hers 第二季度营收为5.448亿美元，较去年同期的3.156亿美元增长73%。该公司报告净利润为4250万美元，合每股收益17美分；而去年同期净利润为1330万美元，合每股收益6美分。</p><p style=\"text-align: start;\">对于第三季度，Hims & Hers 表示预计营收将在5.7亿至5.9亿美元之间，而分析师预期为5.83亿美元。该公司表示，其第三季度调整后的利息、税项、折旧及摊销前利润（EBITDA）预计在6000万至7000万美元之间。StreetAccount 调查的分析师预期为7710万美元。</p><p style=\"text-align: start;\"><strong>争议背景</strong></p><p style=\"text-align: start;\">Hims & Hers 近几个月因其持续销售<strong>复合GLP-1药物</strong>而面临争议。这些药物是热门糖尿病和减肥药物的更便宜、未经批准的版本。当品牌药供应短缺时，复合药物可以大规模生产，但美国食品药品监督管理局（FDA）在2月份宣布，持续的供应问题已得到解决。</p><p style=\"text-align: start;\">包括 Hims & Hers 在内的一些远程医疗公司仍在继续提供这些复合药物。在法律允许的特殊情况下（例如患者对品牌药中的某种成分过敏），患者获取个性化剂量的仿制药是合法的。Hims & Hers 表示，如果临床适用，消费者可能仍能通过其网站获得个性化剂量。</p><p style=\"text-align: start;\">6月，Hims & Hers 与诺和诺德（Novo Nordisk）的短暂合作破裂后，其股价曾暴跌逾30%。诺和诺德表示，Hims & Hers “在个性化的虚假幌子下，未能遵守禁止大规模销售复合药物的法律”。</p><p style=\"text-align: start;\"><strong>其他财务数据</strong></p><p style=\"text-align: start;\">Hims & Hers 报告第二季度调整后 EBITDA 为8200万美元，高于去年同期的3930万美元，也高于 StreetAccount 预期的7300万美元。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hims & Hers 二季度营收增长73%，但未达预期</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHims & Hers 二季度营收增长73%，但未达预期\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2025-08-05 07:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p style=\"text-align: start;\"><strong>关键点</strong></p><ul style=\"\"><li><p>Hims & Hers Health 股价在盘后交易中下跌，此前该公司公布的第二季度营收未达到华尔街的营收预期。</p></li><li><p>营收同比增长73%，达到5.448亿美元。</p></li><li><p>Hims & Hers 报告第二季度调整后 EBITDA 为8200万美元，高于去年同期的3930万美元。</p></li></ul><p style=\"text-align: start;\">Hims & Hers Health (HIMS) 股价周一盘后下跌13%，此前这家远程医疗公司公布的第二季度业绩未达到华尔街的营收预期。</p><p></p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/35dbaa7fe50863ac71a93584bd75c783\" tg-width=\"528\" tg-height=\"154\"/></p><p style=\"text-align: start;\">根据伦敦证券交易所集团（LSEG）汇编的分析师平均预期，该公司业绩如下：</p><ul style=\"\"><li><p><strong>每股收益：</strong> 调整后为17美分，预期为15美分</p></li><li><p><strong>营收：</strong> 5.448亿美元，预期为5.52亿美元</p></li></ul><p style=\"text-align: start;\">根据公告，Hims & Hers 第二季度营收为5.448亿美元，较去年同期的3.156亿美元增长73%。该公司报告净利润为4250万美元，合每股收益17美分；而去年同期净利润为1330万美元，合每股收益6美分。</p><p style=\"text-align: start;\">对于第三季度，Hims & Hers 表示预计营收将在5.7亿至5.9亿美元之间，而分析师预期为5.83亿美元。该公司表示，其第三季度调整后的利息、税项、折旧及摊销前利润（EBITDA）预计在6000万至7000万美元之间。StreetAccount 调查的分析师预期为7710万美元。</p><p style=\"text-align: start;\"><strong>争议背景</strong></p><p style=\"text-align: start;\">Hims & Hers 近几个月因其持续销售<strong>复合GLP-1药物</strong>而面临争议。这些药物是热门糖尿病和减肥药物的更便宜、未经批准的版本。当品牌药供应短缺时，复合药物可以大规模生产，但美国食品药品监督管理局（FDA）在2月份宣布，持续的供应问题已得到解决。</p><p style=\"text-align: start;\">包括 Hims & Hers 在内的一些远程医疗公司仍在继续提供这些复合药物。在法律允许的特殊情况下（例如患者对品牌药中的某种成分过敏），患者获取个性化剂量的仿制药是合法的。Hims & Hers 表示，如果临床适用，消费者可能仍能通过其网站获得个性化剂量。</p><p style=\"text-align: start;\">6月，Hims & Hers 与诺和诺德（Novo Nordisk）的短暂合作破裂后，其股价曾暴跌逾30%。诺和诺德表示，Hims & Hers “在个性化的虚假幌子下，未能遵守禁止大规模销售复合药物的法律”。</p><p style=\"text-align: start;\"><strong>其他财务数据</strong></p><p style=\"text-align: start;\">Hims & Hers 报告第二季度调整后 EBITDA 为8200万美元，高于去年同期的3930万美元，也高于 StreetAccount 预期的7300万美元。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://community-static.tradeup.com/news/8e1c456ca197d0f36009334944bbbcef","relate_stocks":{"HIMS":"Hims & Hers Health Inc."},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199873405","content_text":"关键点Hims & Hers Health 股价在盘后交易中下跌，此前该公司公布的第二季度营收未达到华尔街的营收预期。营收同比增长73%，达到5.448亿美元。Hims & Hers 报告第二季度调整后 EBITDA 为8200万美元，高于去年同期的3930万美元。Hims & Hers Health (HIMS) 股价周一盘后下跌13%，此前这家远程医疗公司公布的第二季度业绩未达到华尔街的营收预期。根据伦敦证券交易所集团（LSEG）汇编的分析师平均预期，该公司业绩如下：每股收益： 调整后为17美分，预期为15美分营收： 5.448亿美元，预期为5.52亿美元根据公告，Hims & Hers 第二季度营收为5.448亿美元，较去年同期的3.156亿美元增长73%。该公司报告净利润为4250万美元，合每股收益17美分；而去年同期净利润为1330万美元，合每股收益6美分。对于第三季度，Hims & Hers 表示预计营收将在5.7亿至5.9亿美元之间，而分析师预期为5.83亿美元。该公司表示，其第三季度调整后的利息、税项、折旧及摊销前利润（EBITDA）预计在6000万至7000万美元之间。StreetAccount 调查的分析师预期为7710万美元。争议背景Hims & Hers 近几个月因其持续销售复合GLP-1药物而面临争议。这些药物是热门糖尿病和减肥药物的更便宜、未经批准的版本。当品牌药供应短缺时，复合药物可以大规模生产，但美国食品药品监督管理局（FDA）在2月份宣布，持续的供应问题已得到解决。包括 Hims & Hers 在内的一些远程医疗公司仍在继续提供这些复合药物。在法律允许的特殊情况下（例如患者对品牌药中的某种成分过敏），患者获取个性化剂量的仿制药是合法的。Hims & Hers 表示，如果临床适用，消费者可能仍能通过其网站获得个性化剂量。6月，Hims & Hers 与诺和诺德（Novo Nordisk）的短暂合作破裂后，其股价曾暴跌逾30%。诺和诺德表示，Hims & Hers “在个性化的虚假幌子下，未能遵守禁止大规模销售复合药物的法律”。其他财务数据Hims & Hers 报告第二季度调整后 EBITDA 为8200万美元，高于去年同期的3930万美元，也高于 StreetAccount 预期的7300万美元。","news_type":1,"symbols_score_info":{"HIMS":1.1}},"isVote":1,"tweetType":1,"viewCount":381,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":464152230854784,"gmtCreate":1754343502961,"gmtModify":1754343859109,"author":{"id":"4206954846470532","authorId":"4206954846470532","name":"糊涂虫141319","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4206954846470532","idStr":"4206954846470532"},"themes":[],"htmlText":"为什么这也不是很差的预期，为什么还暴跌，看不懂","listText":"为什么这也不是很差的预期，为什么还暴跌，看不懂","text":"为什么这也不是很差的预期，为什么还暴跌，看不懂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/464152230854784","repostId":"1154130468","repostType":2,"isVote":1,"tweetType":1,"viewCount":312,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":464147141869704,"gmtCreate":1754342475441,"gmtModify":1754363797282,"author":{"id":"4206954846470532","authorId":"4206954846470532","name":"糊涂虫141319","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4206954846470532","idStr":"4206954846470532"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HIMS\">$Hims & Hers Health Inc.(HIMS)$ </a><v-v data-views=\"0\"></v-v> ","listText":"<a href=\"https://laohu8.com/S/HIMS\">$Hims & Hers Health Inc.(HIMS)$ </a><v-v data-views=\"0\"></v-v> ","text":"$Hims & Hers Health Inc.(HIMS)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/464147141869704","isVote":1,"tweetType":1,"viewCount":251,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":448112226586640,"gmtCreate":1750429174234,"gmtModify":1750429526297,"author":{"id":"4206954846470532","authorId":"4206954846470532","name":"糊涂虫141319","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4206954846470532","idStr":"4206954846470532"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$ </a><v-v data-views=\"1\"></v-v> 横盘那么多天了又有利好","listText":"<a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$ </a><v-v data-views=\"1\"></v-v> 横盘那么多天了又有利好","text":"$特斯拉(TSLA)$ 横盘那么多天了又有利好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/448112226586640","isVote":1,"tweetType":1,"viewCount":356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
